New whitepaper: Toward outcomes-based payments
Aug 11, 2022
In this new report from Reuters Events Pharma, in partnership with Optum, market access and value leaders give their insights on how to generate evidence and demonstrate value for HCP value.
You will discover how to:
- Overcome challenges to ensure outcomes-based contracts become the default standard for negotiation with payers
- Generate evidence early to demonstrate overall efficacy and individual patient outcomes, including common scenarios for an outcomes-based contract
- Accelerate adoption to provide the right therapies to the right patient at the right time, improving quality of life while reducing the long-term cost of care.
Please subscribe to view the analysis report